HIPPOCRATES IMI

HIPPOCRATES is a research initiative in the field of psoriasis and psoriatic arthritis. The purpose of HIPPOCRATES is to promote early identification and improving outcomes in Psoriatic Arthritis (PsA). To reduce the burden of PsA, the HIPPOCRATES consortium brings together world leading clinicians, highly qualified experts and researchers in the field of psoriasis and PsA and people living with the disease. They will work together closely as a team to intensify the search for promising new tests that can guide the future development of new effective treatments for PsA. HIPPOCRATES started in July 2021 and will run for 60 months – a well established team from all over Europe will work together on these ambitious objectives. HIPPOCRATES has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No. 101007757. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. This page reflects the author's view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained therein.